Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000252404 | SCV000319950 | benign | Cardiovascular phenotype | 2018-03-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001704073 | SCV000515978 | likely benign | not provided | 2021-06-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24055113, 21515508, 25637381) |
Labcorp Genetics |
RCV000990616 | SCV000560803 | likely benign | Duchenne muscular dystrophy | 2024-01-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000434520 | SCV000603349 | benign | not specified | 2017-04-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000434520 | SCV000705594 | likely benign | not specified | 2017-03-03 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990616 | SCV001141632 | benign | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293115 | SCV001434105 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Fulgent Genetics, |
RCV002498678 | SCV002807543 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-11-16 | criteria provided, single submitter | clinical testing | |
CSER _CC_NCGL, |
RCV000148463 | SCV000190162 | likely benign | Muscular dystrophy | 2014-06-01 | no assertion criteria provided | research | |
Diagnostic Laboratory, |
RCV001704073 | SCV001978709 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001704073 | SCV001980270 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826799 | SCV002087750 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-03-21 | no assertion criteria provided | clinical testing |